Additionally, it modulates the ROS/ATF3/CHOP pathway to reduce the expression of apoptotic genes DDIT3 (CHOP) and SNCA (α-synuclein, α-syn), thereby inhibiting apoptosis in Parkinson’s disease cell models (Zhao et al., 2016). Here, SNCA is linked to Parkinson disease.